Today: 29 April 2026
Disney stock rises in premarket on CEO successor report, ESPN-NFL deal clearance
2 February 2026
2 mins read

Disney stock rises in premarket on CEO successor report, ESPN-NFL deal clearance

New York, Feb 2, 2026, 05:35 EST — Premarket

  • Disney shares gained roughly 1.1% ahead of the open following a report naming Josh D’Amaro as a top CEO candidate
  • Investors are gearing up for fiscal first-quarter results, set to drop before the bell
  • ESPN has secured regulatory approval to acquire NFL Network assets, consolidating them under its umbrella

Walt Disney (DIS) shares edged up about 1.1% to $112.80 in premarket trading ahead of the U.S. session, following a Bloomberg News report that the board is near choosing parks chief D’Amaro as the next CEO. Reuters hasn’t confirmed the scoop, and Disney didn’t immediately reply to requests for comment. A company spokesperson stated, “The board has not yet selected the next CEO of the Walt Disney Co. and once that decision is made, we will announce it.” Reuters

Disney will drop its fiscal first-quarter numbers ahead of Monday’s market open and follow up with a webcast at 8:30 a.m. ET.

U.S. regulators have approved a major sports-media deal that gives the National Football League a 10% stake in ESPN. In exchange, the NFL is handing over NFL Network, its RedZone Channel linear rights, and other assets. “With the closing, we will begin integrating NFL employees into ESPN in the months ahead,” ESPN and the NFL said. The networks plan to fold NFL Network and RedZone into ESPN’s upcoming direct-to-consumer streaming service, sold directly to viewers, while keeping those channels available on cable and satellite. According to the report, any changes aren’t expected before April. Reuters

D’Amaro leads Disney Experiences, the division that oversees the theme parks—historically a major cash generator for the company. His responsibilities cover Disney Parks, which boasts 12 theme parks and 57 resort hotels spread across six global locations, along with the cruise line and consumer products segments, according to Disney’s website.

Wall Street expects the quarter to reveal steady parks spending and a clearer outlook in streaming, following years of upheaval in traditional TV. Analysts polled by FactSet forecast adjusted earnings of $1.57 per share on revenue around $25.7 billion, according to Barron’s.

The CEO situation adds a layer of complexity. Since Bob Iger came back in 2022—after Disney delayed his retirement and ousted Bob Chapek—investors have been closely monitoring succession plans. Naming a new CEO would bring some clarity or at least signal a direction as Disney navigates a tough year juggling streaming, sports rights, and costly investments in its parks.

That premarket surge often fizzles quickly. If the board drags its feet or opts for another candidate, the buzz around succession could turn out to be nothing more than a brief sugar rush. After that, the stock tends to fall back, refocusing on the earnings results and management’s comments on costs, pricing, and demand.

Traders will be eyeing whether the move sticks when cash trading kicks off at 9:30 a.m. ET. Monday’s earnings report and the 8:30 a.m. ET call come next, with the CEO’s queries still looming and ESPN’s NFL integration ticking down against the clock.

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:56 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open
Previous Story

Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open

Nippon India Silver ETF price today: SILVERBEES slides as silver swings shake bullion ETFs
Next Story

Nippon India Silver ETF price today: SILVERBEES slides as silver swings shake bullion ETFs

Go toTop